[HTML][HTML] Optimizing the personalized, risk-adjusted management of pulmonary embolism: an integrated clinical trial programme
S Barco, SV Konstantinides - Hämostaseologie, 2019 - thieme-connect.com
Acute pulmonary embolism (PE) contributes significantly to the global burden of
cardiovascular disease. The severity of the acute PE event determines the expected …
cardiovascular disease. The severity of the acute PE event determines the expected …
Optimizing the Personalized, Risk-Adjusted Management of Pulmonary Embolism: An Integrated Clinical Trial Programme
S Barco, SV Konstantinides - Hamostaseologie, 2019 - pubmed.ncbi.nlm.nih.gov
Acute pulmonary embolism (PE) contributes significantly to the global burden of
cardiovascular disease. The severity of the acute PE event determines the expected …
cardiovascular disease. The severity of the acute PE event determines the expected …
[PDF][PDF] Optimizing the Personalized, Risk-Adjusted Management of Pulmonary Embolism: An Integrated Clinical Trial Programme
S Barco, SV Konstantinides - Hämostaseologie, 2019 - scholar.archive.org
Acute pulmonary embolism (PE) contributes significantly to the global burden of
cardiovascular disease. The severity of the acute PE event determines the expected …
cardiovascular disease. The severity of the acute PE event determines the expected …
Optimizing the Personalized, Risk-Adjusted Management of Pulmonary Embolism: An Integrated Clinical Trial Programme.
S Barco, SV Konstantinides - Hamostaseologie, 2018 - europepmc.org
Acute pulmonary embolism (PE) contributes significantly to the global burden of
cardiovascular disease. The severity of the acute PE event determines the expected …
cardiovascular disease. The severity of the acute PE event determines the expected …